These results indicated that NDUFS8 might serve as a promising biomarker for early diagnosis in CCH-induced cognitive impairment and redefines therapeutic strategies by simultaneously targeting transcriptional regulation and protein stabilization pathways. Here, NDUFS8 is linked to columnar cell hyperplasia of the breast.